DEFC14A: National Health Investors Faces Proxy Fight Amidst Strong 2024 Performance

National Health Investors reports a return to growth in 2024, outperforming the Nareit Healthcare REIT Index, while simultaneously navigating a proxy contest initiated by Land & Buildings.

Summary

• National Health Investors (NHI) reported a return to growth in 2024, with increases in Nareit Funds from Operations (FFO), Normalized FFO, and Funds Available for Distribution for the first time since 2020.
• NHI's Total Shareholder Return (TSR) was 30.6% in 2024, significantly outperforming the Nareit Healthcare REIT Index.
• The company announced investments of over $235 million at an average yield of approximately 8.6% in 2024.
• NHI capitalized on equity markets, raising net proceeds of approximately $262 million, with $119 million remaining available to settle at December 31, 2024.
• Net debt-to-adjusted EBITDA decreased from 4.5x in 2023 to 4.1x in 2024.
• The Board has grown from four directors to eight since 2020, with female representation increasing from 0% to 37.5% and average tenure decreasing from 21 years to seven years.
• Land & Buildings, owning approximately 1.3% of NHI's shares, intends to propose two nominees for election to the Board.
• The Board recommends voting FOR the election of its four Company Nominees at the annual meeting on May 21, 2025.

Sentiment

Score: 8

Explanation: The document expresses optimism about the company's future prospects, highlighting strong financial performance, strategic investments, and a favorable industry outlook. However, the proxy fight introduces an element of uncertainty.

Positives

• Strong financial performance in 2024, surpassing initial expectations.
• Significant outperformance of the Nareit Healthcare REIT Index in terms of TSR.
• Successful capital allocation with investments at an attractive average yield.
• Improved leverage ratio, indicating a stronger financial position.
• Board refreshment and increased diversity, enhancing its effectiveness.
• Commitment to corporate governance enhancements, including declassifying the Board.

Negatives

• Proxy contest initiated by Land & Buildings, indicating potential disagreement on company direction.
• Land & Buildings owns approximately 1.3% of NHI's shares, which is a relatively small stake, but they are still pursuing board nominees.

Risks

• The outcome of the proxy contest could lead to changes in the Board's composition and strategic direction.
• Negotiations for the NHC lease renewal could be complex and impact future revenues.
• Failure to adapt to changing industry fundamentals could hinder future growth.

Future Outlook

NHI is optimistic that 2025 will be an even more productive year, competitively positioned to capitalize on favorable industry fundamentals in senior housing and expecting multiple years of exceptional growth.

Management Comments

• Our 2024 annual results marked a return to growth as we increased Nareit Funds from Operations (FFO), Normalized FFO, and Funds Available for Distribution for the first time since 2020.
• The strength in our financial profile positions NHI well to deploy capital for future investments and creates a significant strategic advantage as the supply of capital is shrinking just as demand is increasing.
• As operators rush to take advantage of the most favorable industry fundamentals in the history of senior housing, NHI is competitively positioned as the partner of choice which convinces us that we are in the early days of multiple years of exceptional growth.

Industry Context

The announcement highlights NHI's strong positioning in the senior housing sector, particularly as other capital providers scale back their exposure or exit the industry, allowing NHI to move more quickly and capitalize on favorable industry fundamentals.

Comparison to Industry Standards

• NHI's Total Shareholder Return (TSR) of 30.6% significantly outperformed the Nareit Healthcare REIT Index in 2024.
• The document mentions three peers (LTC Properties, Inc.; Sabra Health Care REIT, Inc.; and CareTrust REIT, Inc.) for Total Stockholder Return goals.
• The document mentions a peer group of 9 healthcare REITs and 6 other similarly sized, net-lease REITs for executive compensation benchmarking.

Management Changes

Corporate Governance

Related Party Transactions

• As of December 31, 2024, we leased three independent living facilities and 32 skilled nursing facilities to NHC under a master lease that expires on December 31, 2026.
• Of our total revenues, $40.0 million (12%), $37.3 million (12%) and $36.9 million (13%), in 2024, 2023, and 2022, respectively, were derived from NHC.
• Mr. McCabe, the Chair of our Board, is chairman of the board of directors of Pinnacle and, based upon the advice of our legal counsel, our banking relationship with Pinnacle National Bank is not prohibited by law or regulation.
• Pinnacle National Bank participates in our senior unsecured credit facility.

Stakeholder Impact

• Shareholders: Strong financial performance and TSR outperformance benefit shareholders.
• Employees: Competitive compensation and benefits programs attract and retain talent.
• Residents: Investments in properties and facilities improve the quality of care and living environments.
• Operating Partners: Capital improvement allowances and development partnerships support their growth and success.
• Community: Charitable contributions and support for local organizations benefit the communities served.

Next Steps

• Stockholders will vote on the election of directors, the declassification of the Board, executive compensation, and the ratification of the independent registered public accounting firm at the annual meeting on May 21, 2025.
• The Board will consider the outcome of the say-on-pay vote and evaluate whether any actions are necessary to address stockholder concerns.
• The company will publish its Inaugural Sustainability Report in 2025.

Key Dates

Keywords

proxy fight, board of directors, corporate governance, shareholder return, senior housing, real estate investment trust, National Health Investors, investments, FFO, EBITDA